Specific resources for individuals about prescribed drug dependence are available on the Lived and professional Experience Advisory Panel (leap4pdd) site: @samaritans #antidepressants #informedconsent #panorama https://t.co/NEs5dIV7id

We worked with The New York Times Magazine to speak to young people in our community about how the absence of informed consent has resulted in impactful, life-altering consequences for them. This landmark investigation shines a light on what has been a dark, hidden space for

If you’re in the NYC area, please come to @joannamoncrieff’s talk on Tuesday, Dec 2, at Columbia University, on her wonderful and timely book, Chemically Imbalanced.

A new qualitative study from Trinity College Dublin reveals the emotional and physical toll of psychiatric drug withdrawal—and the lack of professional support available to those trying to stop. https://t.co/8l0zhU8v2N

To mark #MedSafetyWeek, LEAP4PDD (@LEAP4PDD) has published a Yellow Card Reporting Toolkit. If you’ve been harmed by prescribed psych drugs, you can play a vital role in improving safety for future patients simply by spending 10 minutes filing a Yellow Card report. 👇

It’s Medicines Safety Week - have you experienced an adverse effect from a prescribed drug? If you haven’t already, do report it through the Yellow Card Scheme - here’s a link to a step-by-step toolkit. #medsafetyweek #patientsafety @JDaviesPhD https://t.co/lYWMjZrJhe

We published a paper on why to hyperbolically taper opioids with Professor Sir John Strang, Director of the National Addiction Centre. The law of mass action dictates all drug relationships. NICE issued advice (NG 215) based on a draft of this paper. https://t.co/KIpHZLuQw1

There is no ‘neuro’ in neurodiversity

65M Americans take psychiatric drugs. 1 in 4 adults. Nearly 1 in 10 kids. Millions are medicated, numbed, and stuck with no safe way out. If this affects you—or someone you love—this thread matters 🧵

So exciting that the French research council has agreed to fund a randomised trial of hyperbolic tapering of antidepressants led by the dynamic Dr Maeva Musso. Compared to maintenance in remitted pts on ADs for 6-24 months, examining relapse.

Nice to get a thank you letter from the president of @RANZCP about our webinar last week that 600 psychiatrists attended. Good that the recording will be on their learning platform soon.

The Instagram account @TruePerspectiv3 posted this montage video made up of several clips of various people, including @TuckerCarlson, @LauraDelano, @DrJosefWD, and @freyaindiaa, talking about Post-SSRI Sexual Dysfunction (PSSD).

MAHA or no MAHA we know that anti-depressants in young people are ineffective and increase risk of suicide, a fact that too many psychiatrists are in denial about

🚨 Record numbers of adults and children on antidepressants as major study shows the drugs are ineffective for most ⁦@carlheneghan⁩

🌍 ACE Campaign Update: International Reporting Now Included Our campaign page has been updated! In addition to the FDA reporting links, we’ve now added: ✅ Direct links to report antidepressant withdrawal in: 🇨🇦 Canada 🇬🇧 United Kingdom 🇦🇺 Australia ✅ PLUS a full list of

Trump told Disney to cancel Jimmy Kimmel. So Disney bent at the knee and canceled Kimmel. Maybe it’s time for Democrats and Liberals to cancel Disney? Our annual trip to Disney Orlando won’t happen. Disney Channel was canceled yesterday. I’m only one. There are millions

🧵 1/ This is my harsh reality of psychiatric drug withdrawal. Many patients are forced to turn their kitchens into makeshift pharmacies to taper or reinstate psychiatric drugs; crushing tablets, weighing powder on mg scales, mixing suspensions and using syringes.

Good to see the final version of this paper in print from @jamieroneill Tapering drugs by dosing every second day risks severe withdrawal effects and is generally not wise. Better to use smaller doses e.g. liquids or compounded versions each day https://t.co/VnXO5DYB8D

Thank you so much @markhoro for putting the new data into context with clear, evidence-based analysis. You highlight that withdrawal is real and often linked to duration of use - reaffirming the need for caution and helping people make informed choices on antidepressants.

https://t.co/BEo1WDeT4M

SPECIAL REPORT | Antidepressant withdrawal is a pervasive clinical issue that remains significantly underrecognized and inadequately addressed. Safe deprescribing warrants greater attention as a core component of high-quality psychiatric care.